About Cochlear (ASX:COH)
Cochlear Limited is engaged in providing implantable hearing solutions. The Company's implant systems comprise an implant, which is inserted during surgery and an external sound processor. The Company operates through three segments, based on geographical basis: Americas, EMEA and Asia Pacific. Americas includes the United States, Canada and Latin America. EMEA includes Europe, Middle East and Africa. Asia Pacific includes Australasia and Asia. The Company's products and solutions include Cochlear implants, such as Nucleus 6 System and Aqua+; Bone conduction implants, such as Baha Attract and Baha Connect; Acoustic implant solutions, such as Cochlear Carina System, Cochlear MET System and Cochlear Codacs System, and Cochlear True Wireless range, such as Cochlear WIRELESS Mini Microphone 2, Cochlear Wireless Mini Microphone 2+, Cochlear Wireless Phone Clip and Cochlear Wireless TV Streamer. The Company sells its products in over 100 countries.
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Trailing P/E Ratio46.1007556675063
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity41.48%
Return on Assets19.99%
Cochlear (ASX:COH) Frequently Asked Questions
What is Cochlear's stock symbol?
Cochlear trades on the ASX under the ticker symbol "COH."
When will Cochlear make its next earnings announcement?
Who are some of Cochlear's key competitors?
Some companies that are related to Cochlear include Medivation (MDVN), Ramsay Health Care (RHC), CareFusion (CFN), AEGON (AGN), Bioverativ (BIVV), Salix Pharmaceuticals (SLXP), Kite Pharma (KITE), Sonic Healthcare (SHL), Merck KGaA (MRK), Juno Therapeutics (JUNO), Qiagen (QGEN), Valeant Pharmaceuticals Intl (VRX), NMC Health (NMC), Sirona Dental Systems (SIRO), Encompass Health (EHC), Shire-Nps Pharmaceuticals (NPSP), Anacor Pharmaceuticals (ANAC) and Alere (ALR).
Who are Cochlear's key executives?
Cochlear's management team includes the folowing people:
- Diggory William Howitt, President, Chief Executive Officer, Executive Director
- Brent Cubis, Chief Financial Officer
- Anthony Bishop, President - Asia Pacific
- Richard Brook, President - European Region, Middle East and Africa Region
- Tony Manna, President, Americas Region
- Stuart Sayers, President - Services
- Dean Phizacklea, Senior Vice President, Global Marketing
- Jan Janssen, Senior Vice President - Research and Development
- Katharine McLennan, Senior Vice President - People and Culture
- Ray Jarman, Company Secretary
Has Cochlear been receiving favorable news coverage?
News articles about COH stock have been trending somewhat negative on Saturday, according to Accern Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cochlear earned a coverage optimism score of -0.02 on Accern's scale. They also assigned news headlines about the company an impact score of 46.65 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
What is Cochlear's stock price today?
One share of COH stock can currently be purchased for approximately A$183.02.
How big of a company is Cochlear?
Cochlear has a market capitalization of $11.06 billion.
How can I contact Cochlear?
Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company can be reached via phone at +61-2-94286555.
MarketBeat Community Rating for Cochlear (COH)MarketBeat's community ratings are surveys of what our community members think about Cochlear and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Cochlear (ASX:COH) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Cochlear (ASX:COH) Earnings History and Estimates Chart
Cochlear (ASX COH) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Cochlear (ASX:COH) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Cochlear (ASX:COH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Cochlear (ASX COH)
No insider trades for this company have been tracked by MarketBeat.com
Cochlear (ASX COH) News Headlines
Cochlear (ASX:COH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Cochlear (ASX COH) Stock Chart for Saturday, March, 24, 2018